Uranus Chemicals Co., LTD. (TPEX:7742)
Taiwan
· Delayed Price · Currency is TWD 195.00
+23.50 (13.70%)
At close: Apr 28, 2026
TPEX:7742 Revenue
In the year 2025, Uranus Chemicals Co., LTD. had annual revenue of 1.17B TWD with 42.43% growth. Uranus Chemicals Co., LTD. had revenue of 871.68M in the half year ending December 31, 2025, with 122.56% growth.
Revenue
1.17B
Revenue Growth
+42.43%
P/S Ratio
11.60
Revenue / Employee
10.84M
Employees
108
Market Cap
13.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | 348.74M | 42.43% |
| Dec 31, 2024 | 821.91M | 95.62M | 13.17% |
| Dec 31, 2023 | 726.29M | -591.46M | -44.88% |
| Dec 31, 2022 | 1.32B | 323.82M | 32.58% |
| Dec 31, 2021 | 993.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wonderful Hi-tech | 8.63B |
| APAC Opto Electronics | 814.69M |
| Key Ware Electronics | 1.41B |
| CoAsia Electronics | 34.70B |
| TaiMed Biologics | 611.35M |
| Actron Technology | 8.11B |
| Cica-Huntek Chemical Technology Taiwan | 3.82B |
| TCI Co., Ltd. | 6.99B |